Gail D Anderson
Overview
Explore the profile of Gail D Anderson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
1788
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Predicting Unbound Phenytoin Concentrations: Effects of Albumin Concentration and Kidney Dysfunction
Montgomery M, Chou J, McPharlin T, Baird G, Anderson G
Pharmacotherapy
. 2019 May;
39(7):756-766.
PMID: 31067355
Study Objective: Several methods are available to predict unbound (free) phenytoin concentrations in patients with hypoalbuminemia; however, predictive methods have not been evaluated in patients with concurrent hypoalbuminemia and kidney...
2.
Goss C, Kaneko Y, Khuu L, Anderson G, Ravishankar S, Aitken M, et al.
Sci Transl Med
. 2018 Sep;
10(460).
PMID: 30257953
The lack of new antibiotics is among the most critical challenges facing medicine. The problem is particularly acute for Gram-negative bacteria. An unconventional antibiotic strategy is to target bacterial nutrition...
3.
Anderson G, Hakimian S
Drugs Aging
. 2018 Jul;
35(8):687-698.
PMID: 30003428
The incidence of epilepsy is highest in the older adult age group. Seizures in older adults can be more difficult to diagnose because their presentation is often subtle and can...
4.
Hart L, Anderson G
Clin Pharmacokinet
. 2018 Jan;
57(8):943-976.
PMID: 29357102
International guidelines recommend the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) method to monitor kidney function in chronic kidney disease using either creatinine- or cystatin C-based estimation methods. The choice of...
5.
Airhart S, Shireman L, Risler L, Anderson G, Gowda G, Raftery D, et al.
PLoS One
. 2017 Dec;
12(12):e0186459.
PMID: 29211728
Objectives: The co-primary objectives of this study were to determine the human pharmacokinetics (PK) of oral NR and the effect of NR on whole blood nicotinamide adenine dinucleotide (NAD+) levels....
6.
Vossler D, Anderson G, Bainbridge J
Epilepsy Curr
. 2016 Jun;
16(3):209-11.
PMID: 27330454
No abstract available.
7.
Anderson G, Chan L
Clin Pharmacokinet
. 2016 Apr;
55(11):1353-1368.
PMID: 27106177
Tobacco smoke contains a large number of compounds in the form of metals, volatile gases and insoluble particles, as well as nicotine, a highly addictive alkaloid. Marijuana is the most...
8.
Anderson G, Saneto R
CNS Drugs
. 2015 Sep;
29(8):669-81.
PMID: 26369919
Modified-release or extended-release (XR) formulations are used to decrease the frequency of dosing for drugs with rapid elimination, to improve convenience and adherence. Use of a modified-release formulation can decrease...
9.
Peterson T, Maass W, Anderson J, Anderson G, Hoane M
Behav Brain Res
. 2015 Aug;
294:254-63.
PMID: 26275924
Our primary goal was to evaluate the behavioral and histological outcome of fluid percussion injury (FPI) and cortical contusion injury (CCI) to the sensorimotor cortex (SMC). The SMC has been...
10.
Anderson G, Peterson T, Vonder Haar C, Farin F, Bammler T, MacDonald J, et al.
AAPS J
. 2015 Jun;
17(5):1255-67.
PMID: 26068867
In contrast to considerable data demonstrating a decrease in cytochrome P450 (CYP) activity in inflammation and infection, clinically, traumatic brain injury (TBI) results in an increase in CYP and UDP...